PVI
TARS icon

Pura Vida Investments’s Tarsus Pharmaceuticals TARS Stock Holding History

Pura Vida Investments’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,686
Closed -$484K – 328
2021
Q2 		$484K Buy
+16,686
New +$521K 0.02% 201

Other funds holding TARS

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Pura Vida Investments's TARS Position: Q3 2021 in Review

Pura Vida Investments sold out of Tarsus Pharmaceuticals (TARS) in Q3 2021, closing a stake of 16,686 shares — an estimated $484K sold.

Pura Vida Investments first reported a position in TARS in Q2 2021 and held it in 1 quarter. The position peaked at $484K in Q2 2021. 44 funds tracked by Wall St. Rank hold TARS as of Q3 2021.

  • Pura Vida Investments reported no remaining Tarsus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 16,686 Tarsus Pharmaceuticals shares in Q3 2021, an estimated $484K.
  • Pura Vida Investments first reported a position in Tarsus Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Pura Vida Investments's Tarsus Pharmaceuticals position peaked at $484K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.